IP Library › Assignment 015247/0597
Patent Assignment
Reel/Frame 015247/0597

Merger

Recorded: 2004-10-14 Pages: 5
Assignor
NAPRO BIOTHERAPEUTICS, INC.
Executed: 2004-05-27
Assignee
TAPESTRY PHARMACEUTICALS, INC.
4840 PEARL EAST CIRCLE, SUITE 300W, BOULDER, COLORADO, 80301
Covered Property (1)
Locked Nucleic Acid Hybrids and Methods of Use
Patent: 6,977,295 →
Application: 09/557,423 →
Publication: US 2002/0094555
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2000
From: BELOTSERKOVSKII, BORIS P.; REDDY, GURUCHARAN; ZARLING, DAVID A.
To: PANGENE CORPORATION
Reel/Frame 011316/0169 →
Assignment of Assignor's Interest Jan 24, 2003
From: PANGENE CORPORATION
To: NAPRO BIO THERAPEUTICS, INC.
Reel/Frame 013697/0960 →
Assignment of Assignor's Interest Jun 7, 2005
From: TAPESTRY PHARMACEUTICALS, INC.
To: INVITROGEN CORPORATION
Reel/Frame 016100/0749 →
Merger Feb 3, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023882/0551 →
Corrective Assignment to Correct the Application No 09452626 Previously Recorded on Reel 023882 Frame 0551. Assignor(S) Hereby Confirms the Merger Should Not Have Been Recorded Against This Patent Application Number. Nov 14, 2014
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 034217/0490 →